These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9665271)

  • 21. Endotoxin interactions with lipopolysaccharide-responsive cells.
    Tobias PS; Tapping RI; Gegner JA
    Clin Infect Dis; 1999 Mar; 28(3):476-81. PubMed ID: 10194064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surfactant protein a inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein.
    Stamme C; Müller M; Hamann L; Gutsmann T; Seydel U
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):353-60. PubMed ID: 12204898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual effects of soluble CD14 on LPS priming of neutrophils.
    Troelstra A; Giepmans BN; Van Kessel KP; Lichenstein HS; Verhoef J; Van Strijp JA
    J Leukoc Biol; 1997 Feb; 61(2):173-8. PubMed ID: 9021923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria.
    Le Roy D; Di Padova F; Adachi Y; Glauser MP; Calandra T; Heumann D
    J Immunol; 2001 Sep; 167(5):2759-65. PubMed ID: 11509620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes.
    Schromm AB; Brandenburg K; Rietschel ET; Flad HD; Carroll SF; Seydel U
    FEBS Lett; 1996 Dec; 399(3):267-71. PubMed ID: 8985160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein.
    Hamann L; Stamme C; Ulmer AJ; Schumann RR
    Biochem Biophys Res Commun; 2002 Jul; 295(2):553-60. PubMed ID: 12150986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.
    Dunzendorfer S; Lee HK; Soldau K; Tobias PS
    FASEB J; 2004 Jul; 18(10):1117-9. PubMed ID: 15132988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.
    Ryu JK; Kim SJ; Rah SH; Kang JI; Jung HE; Lee D; Lee HK; Lee JO; Park BS; Yoon TY; Kim HM
    Immunity; 2017 Jan; 46(1):38-50. PubMed ID: 27986454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.
    Hamann L; Alexander C; Stamme C; Zähringer U; Schumann RR
    Infect Immun; 2005 Jan; 73(1):193-200. PubMed ID: 15618154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein.
    Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ
    J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.
    Wurfel MM; Hailman E; Wright SD
    J Exp Med; 1995 May; 181(5):1743-54. PubMed ID: 7536794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
    Kitchens RL; Ulevitch RJ; Munford RS
    J Exp Med; 1992 Aug; 176(2):485-94. PubMed ID: 1380063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
    Ulevitch RJ; Tobias PS
    Annu Rev Immunol; 1995; 13():437-57. PubMed ID: 7542010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide.
    Dziarski R; Viriyakosol S; Kirkland TN; Gupta D
    Infect Immun; 2000 Sep; 68(9):5254-60. PubMed ID: 10948152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.
    Pugin J; Schürer-Maly CC; Leturcq D; Moriarty A; Ulevitch RJ; Tobias PS
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2744-8. PubMed ID: 7681988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster.
    Triantafilou M; Triantafilou K
    Trends Immunol; 2002 Jun; 23(6):301-4. PubMed ID: 12072369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
    Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
    J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of LBP in intracellular LPS-signaling.
    Kopp F; Kupsch S; Schromm AB
    Biochim Biophys Acta; 2016 Apr; 1863(4):660-72. PubMed ID: 26804480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors.
    Ingalls RR; Heine H; Lien E; Yoshimura A; Golenbock D
    Infect Dis Clin North Am; 1999 Jun; 13(2):341-53, vii. PubMed ID: 10340170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.